Manufacturer
KOTRA PHARMA (M) SDN. BHD.
Contents
Mometasone furoate (micronised)
Indication
Nasal polyps, Allergic rhinitis
Instruction
Adult: As 0.05% susp: 100 mcg into each nostril once daily, increased to 200 mcg into each nostril daily if needed.
Child: 3-11 yr 50 mcg into each nostril once daily; ≥12 yr Same as adult dose.
Drug interaction
Strong CYP3A4 inhibitors (e.g. ketoconazole) may increase systemic exposure of mometasone.
Malaysia
